MEDLAB CLINICAL LIMITED Notification of Consolidation/Split
Announcement Summary
For personal use only
Entity name
MEDLAB CLINICAL LIMITED
Applicable security for the reorganisation
MDC | ORDINARY FULLY PAID |
MDCAP | OPTION EXPIRING 16-OCT-2024 EX $0.21 |
MDCAL | OPTION EXPIRING 31-OCT-2022 EX $0.18 |
MDCAM | OPTION EXPIRING 31-OCT-2022 EX $0.20 |
MDCAN | OPTION EXPIRING 24-JUN-2024 EX $0.275 |
MDCAO | OPTION EXPIRING 24-JUN-2024 EX $0.21 |
Announcement Type | |
New Announcement | |
Date of this announcement | |
29/6/2022 | |
Reorganisation type | |
Security consolidation |
Trading in the post consolidation or split +securities commences on a deferred settlement basis
2/8/2022
Record Date
3/8/2022
Issue Date
10/8/2022
Refer to below for full details of the announcement
Notification of Consolidation/Split | 1 / 6 |
Notification of Consolidation/Split
Announcement Details
only | ||||
Part 1 - Entity and announcement details | ||||
1.1 Name of +Entity | ||||
MEDLAB CLINICAL LIMITED | ||||
1.2 Registered Number Type | Registration Number | |||
use | ACN | |||
169149071 | ||||
1.3 ASX issuer code | ||||
MDC | ||||
1.4 The announcement is | ||||
personal | New announcement | |||
1.5 Date of this announcement | ||||
29/6/2022 | ||||
1.6 Securities affected by the consolidation or split | ||||
ASX +Security Code | ASX +Security Description | |||
MDC | ORDINARY FULLY PAID | |||
MDCAP | OPTION EXPIRING 16-OCT-2024 EX $0.21 | |||
For | MDCAL | OPTION EXPIRING 31-OCT-2022 EX $0.18 | ||
MDCAM | OPTION EXPIRING 31-OCT-2022 EX $0.20 | |||
MDCAN | OPTION EXPIRING 24-JUN-2024 EX $0.275 | |||
MDCAO | OPTION EXPIRING 24-JUN-2024 EX $0.21 |
Notification of Consolidation/Split | 2 / 6 |
Notification of Consolidation/Split
Part 2 - Approvals
2.1 Are any of the below approvals required for the consolidation or split before business day 0 of the timetable? Security holder approval
Court approval
Lodgement of court order with +ASIC
ACCC approval
FIRB approval
Another approval/condition external to the entity required to be given/met before business day 0 of the timetable for the consolidation or split.
only | Yes | ||||||
2.2 | Approvals | ||||||
use | Approval/Condition | Date for determination | Is the date estimated or | Approval | |||
+Security holder approval | 28/7/2022 | actual? | received/condition met? | ||||
Estimated | |||||||
Comments | |||||||
personal | |||||||
Part 3 - Consolidation or split timetable and details | |||||||
3.1 | +Record date | ||||||
3/8/2022 | |||||||
3.2 | Date of +security holder meeting | ||||||
28/7/2022 | |||||||
3.2a Effective date of consolidation or split | |||||||
29/7/2022 | |||||||
3.3 | Last day for trading in the pre consolidation or split +securities | ||||||
1/8/2022 | |||||||
3.4 | Trading in the post consolidation or split +securities commences on a deferred settlement basis. | ||||||
For | 2/8/2022 | ||||||
3.5 | Record date | ||||||
3/8/2022 |
3.6 First day for entity to update its register and to send holding statements to +security holders reflecting the change in the number of +securities they hold.
4/8/2022
3.7 Last day for entity to update its register and send holding statements to +security holders reflecting the change in the number of +securities they hold and to notify ASX that this has occurred. (+Issue Date)
10/8/2022
Notification of Consolidation/Split | 3 / 6 |
Notification of Consolidation/Split
3.8 Trading starts on a normal T+2 basis
11/8/2022
3.9 First settlement of trades conducted on a +deferred settlement basis and on a normal T+2 basis
15/8/2022
only | ||||
Part 4 - Event type and details | ||||
4.1 The event is | ||||
+Security consolidation | ||||
4.1a Consolidation ratio: the +securities will be consolidated on the basis that every | ||||
use | 150 | |||
(pre-consolidation) +securities will be consolidated into | ||||
1 | ||||
(post-consolidation) +security (/ies). | ||||
personal | 4.2 Scrip fraction rounding | |||
Fractions rounded up to the next whole number | ||||
Part 5 - +Securities on issue before and after consolidation or split | ||||
5.1 +Securities on issue before and after the consolidation or split | ||||
ASX +Security Code | ASX +Security Description | |||
MDC | ORDINARY FULLY PAID | |||
Quoted/unquoted | Number on issue pre | Number on issue post | ||
Quoted | consolidation or split | consolidation or split | ||
342,175,671 | 2,281,171 | |||
For | ASX +Security Code | ASX +Security Description | ||
MDCAP | OPTION EXPIRING 16-OCT-2024 EX $0.21 | |||
Quoted/unquoted | Number on issue pre | Number on issue post | ||
Unquoted | consolidation or split | consolidation or split | ||
1,500,000 | 10,000 | |||
ASX +Security Code | ASX +Security Description | |||
MDCAL | OPTION EXPIRING 31-OCT-2022 EX $0.18 | |||
Quoted/unquoted | Number on issue pre | Number on issue post | ||
Unquoted | consolidation or split | consolidation or split | ||
4,000,000 | 26,667 |
Estimate/Actual
Estimated
Estimate/Actual
Estimated
Estimate/Actual
Estimated
Notification of Consolidation/Split | 4 / 6 |
Notification of Consolidation/Split
use only
ASX +Security Code | ASX +Security Description | ||
MDCAM | OPTION EXPIRING 31-OCT-2022 EX $0.20 | ||
Quoted/unquoted | Number on issue pre | Number on issue post | Estimate/Actual |
Unquoted | consolidation or split | consolidation or split | Estimated |
8,000,000 | 53,333 | ||
ASX +Security Code | ASX +Security Description | ||
MDCAN | OPTION EXPIRING 24-JUN-2024 EX $0.275 | ||
Quoted/unquoted | Number on issue pre | Number on issue post | Estimate/Actual |
Unquoted | consolidation or split | consolidation or split | Estimated |
833,333 | 5,556 | ||
ASX +Security Code | ASX +Security Description | ||
MDCAO | OPTION EXPIRING 24-JUN-2024 EX $0.21 | ||
Quoted/unquoted | Number on issue pre | Number on issue post | Estimate/Actual |
Unquoted | consolidation or split | consolidation or split | Estimated |
250,000 | 1,667 | ||
5.2 Exercise price of options | |||
ASX +Security Code | ASX +Security Description | ||
MDCAP | OPTION EXPIRING 16-OCT-2024 EX $0.21 | ||
Quoted/unquoted | Exercise price pre consolidation or Exercise price post consolidation or | ||
Unquoted | split | split | |
For personal
ASX +Security Code
MDCAL
Quoted/unquoted
Unquoted
ASX +Security Code
MDCAM
Quoted/unquoted
Unquoted
ASX +Security Code
MDCAN
Quoted/unquoted
Unquoted
0.2100000031.50000000
ASX +Security Description
OPTION EXPIRING 31-OCT-2022 EX $0.18
Exercise price pre consolidation or | Exercise price post consolidation or |
split | split |
0.18000000 | 27.00000000 |
ASX +Security Description
OPTION EXPIRING 31-OCT-2022 EX $0.20
Exercise price pre consolidation or | Exercise price post consolidation or |
split | split |
0.20000000 | 30.00000000 |
ASX +Security Description
OPTION EXPIRING 24-JUN-2024 EX $0.275
Exercise price pre consolidation or | Exercise price post consolidation or |
split | split |
0.27500000 | 41.25000000 |
Notification of Consolidation/Split | 5 / 6 |
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Medlab Clinical Ltd. published this content on 29 June 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 29 June 2022 22:31:01 UTC.
